Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Drive Wealth Management LLC

Drive Wealth Management LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,286 shares of the medical equipment provider’s stock after buying an additional 37 shares during the quarter. Drive Wealth Management LLC’s holdings in Intuitive Surgical were worth $671,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. AQR Capital Management LLC raised its holdings in Intuitive Surgical by 12.6% during the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after purchasing an additional 4,775 shares in the last quarter. MidWestOne Financial Group Inc. boosted its stake in Intuitive Surgical by 5.4% during the second quarter. MidWestOne Financial Group Inc. now owns 777 shares of the medical equipment provider’s stock valued at $346,000 after buying an additional 40 shares in the last quarter. Buck Wealth Strategies LLC acquired a new position in Intuitive Surgical during the second quarter worth about $311,000. Creative Planning raised its position in Intuitive Surgical by 9.8% in the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock worth $28,043,000 after acquiring an additional 5,629 shares in the last quarter. Finally, NewEdge Advisors LLC lifted its holdings in Intuitive Surgical by 8.2% in the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after acquiring an additional 1,044 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,453 shares of company stock valued at $22,059,506 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 4.0 %

NASDAQ ISRG opened at $584.05 on Monday. The company has a market capitalization of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm’s fifty day simple moving average is $547.16 and its 200-day simple moving average is $504.78.

Analyst Ratings Changes

A number of research firms recently commented on ISRG. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.